Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing camrelizumab plus stereotactic body radiotherapy versus camrelizumab alone in oligometastatic nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis [Phase 2]
Phase 2 clinical trial update for Tegio consolidation therapy in nasopharyngeal carcinoma patients at high risk of metastasis.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating sintilimab with multimodal radiotherapy in recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC [Phase 2, Phase 3]
An open-label Phase II/III randomized trial comparing PFLL versus GP combined with JS001 as first-line therapy for metastatic nasopharyngeal…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating toripalimab plus surgery versus surgery alone in resectable recurrent nasopharyngeal carcinoma is currently recruit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma [Phase 2]
Phase II trial of camrelizumab in patients with nasopharyngeal carcinoma without distant metastasis is being conducted; current status is un…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating paclitaxel albumin-bound with cisplatin, PD-1 inhibitors, and IMRT in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating paclitaxel albumin-bound with radiotherapy for early-stage nasopharyngeal carcinoma is ongoing but results are not …
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating S-1 combined with IMRT concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Endostar for Locally Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update for Endostar in locally recurrent nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT [Phase 3]
Phase 3 trial evaluating the role of concurrent chemotherapy for lower risk locally advanced nasopharyngeal carcinoma in the IMRT era.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update evaluating nimotuzumab in combination with VMAT for elderly patients with nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma [Phase 2, Phase 3]
Phase 2/3 trial update exploring optimized induction chemotherapy and concurrent chemoradiotherapy with reduced treatment intensity for naso…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update for LONSURF in recurrent/metastatic nasopharyngeal carcinoma is reported, status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pembrolizumab in combination with vorinostat for recurrent, metastatic, or unresectable squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial evaluating toripalimab with concurrent chemoradiotherapy in unresectable locally recurrent nasopharyngeal carcinoma is curre…
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial comparing reduced versus conventional dosage intensity-modulated radiotherapy in chemotherapy-sensitive stage II-III nasopha…
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Treatment of Bevacizumab Followed by Steroid in RN [Phase 2]
Phase 2 clinical trial investigating bevacizumab followed by steroid for treatment of radiation-induced injury in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating camrelizumab plus apatinib in PD-1 antagonist–resistant recurrent/metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
A phase 2 trial evaluating camrelizumab in combination with apatinib as first-line therapy for platinum-resistant recurrent/metastatic nasop…
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation [Phase 2]
Phase II clinical trial update for Treprilimab in recurrent nasopharyngeal carcinoma after re-irradiation.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial comparing proton versus photon radiotherapy for nasopharyngeal carcinoma is ongoing with unclear status.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis [Phase 3]
Phase 3 trial investigating interleukin-11 for prevention and treatment of radioactive oral mucositis in nasopharyngeal carcinoma patients.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC [Phase 2]
Phase 2 clinical trial update for EBV-TCR-T (YT-E001) in EBV-positive recurrent or metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update evaluating concurrent chemoradiotherapy for stage II nasopharyngeal carcinoma has completed enrollment.